News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
Top Biotechs at ASCO: Michelle Xia on Building Akeso and Advancing Dual-Target Immunotherapy
Jun 30, 2025, 06:07

Top Biotechs at ASCO: Michelle Xia on Building Akeso and Advancing Dual-Target Immunotherapy

In this episode of Top Biotechs at ASCO, recorded at ASCO 2025, Dr. Michelle Xia, Founder and CEO of Akeso Biopharma, shares the remarkable journey of building one of China’s leading biopharma companies. Founded in 2012 with just four people, Akeso has grown into a fully integrated company with over 3,400 employees across drug discovery, development, manufacturing, and commercialization.

Akeso is a global leader in bispecific antibody innovation, with two bispecifics—Cadonilimab (PD-1/CTLA-4) and Ivonescimab (VEGF/PD-1)—already commercialized in China. Cadonilimab has received approval for cervical and gastric cancers, and data from its use in first-line cervical cancer was highlighted in an oral presentation at ASCO 2025.

Akeso Biopharma ASCO ASCO 2025 cancer Dr. Michelle Xia OncoDaily Oncology TOP Biotechs at ASCO
Special Coverage
Dialogues
Jun 30, 2025, 06:07
Top Biotechs at ASCO: Michelle Xia on Building Akeso and Advancing Dual-Target Immunotherapy
Blog
Jun 30, 2025, 05:59
Saad Nasir Reflects on MASCC 2025 Experience, Mentorship, and Supportive Care Insights
Insight
Jun 30, 2025, 05:57
Greek Minister of Health Adonis Georgiadis Highlights the Launch of the National Cancer Hub at the 2nd Synergies Forum
Blog
Jun 30, 2025, 05:44
Ghida Talal: Proud to Launch The Lancet Oncology Middle East Series a Testament to Our Region’s Scientific Potential
Insight
Jun 30, 2025, 05:33
George Kapetanakis Announced ELLOK’s Designation as Greece's National Cancer Mission Hub at 2nd Forum on Cancer Synergies
Blog
Jun 30, 2025, 05:31
Al-Ola A. Abdallah Breaks Down Trump’s “Big Beautiful Bill” and Its Impact on U.S. Healthcare
Insight
Jun 30, 2025, 05:12
Elvina Almuradova: Could BC Treatments Impact Alzheimer’s Risk?
Blog
Jun 30, 2025, 04:52
FDA Oncology Highlights CURE ID for Sharing Off-Label Treatment Experiences in Rare Cancer
Insight
Jun 30, 2025, 04:43
Galip Can Uyar: Can Survivor Stories Heal Distress?
Insight
Jun 30, 2025, 04:37
Karima Oualla: Excellent Talk by Marc-Olivier Timsit on the Management of Non Clear Cell Kidney Cancer at IMIBE 2025
Blog
Jun 30, 2025, 04:14
Asim Bag Highlights Case Submissions from 14 Countries for the 3rd Pediatric Neuro-Oncologic Imaging Education Course
Career
Jun 30, 2025, 03:46
Vyshak Alva Venur Became Associate Professor of Medicine at the University of Washington and Fred Hutch Cancer Center